Washington University School of Medicine: clinical-trial pipeline
Washington University School of Medicine is the sponsor of 1,790 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 363 are not yet finished and 14 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Open trials363
Phase 2/3 and 363
Countries36
New in 90 days14
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 1,027 |
| Phase 2 | 261 |
| Phase 1 | 226 |
| Phase 1/2 | 77 |
| Early phase 1 | 69 |
| Phase 4 | 67 |
| Phase 3 | 44 |
| Phase 2/3 | 19 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 1,038 |
| Terminated | 253 |
| Recruiting | 229 |
| Withdrawn or not authorised | 104 |
| Active, not recruiting | 98 |
| Not yet recruiting | 36 |
| Unknown | 27 |
| Suspended or halted | 5 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 597 |
| Metabolic and endocrine (diabetes, obesity) | 176 |
| Cardiovascular | 154 |
| Neurology | 151 |
| Infectious disease and vaccines | 134 |
| Psychiatry and mental health | 128 |
| Gastroenterology and liver | 112 |
| Women's health and obstetrics | 112 |
| Rare and genetic diseases | 103 |
| Nephrology and urology | 70 |
| Immunology and rheumatology | 59 |
| Respiratory | 54 |
Countries
| Country | Trials |
|---|---|
| United States | 1,592 |
| Canada | 22 |
| Malawi | 22 |
| Nigeria | 16 |
| Uganda | 15 |
| Ghana | 9 |
| Sierra Leone | 9 |
| Germany | 7 |
| United Kingdom | 7 |
| Colombia | 6 |
| Spain | 6 |
| France | 6 |
| Italy | 6 |
| Netherlands | 6 |
| Australia | 5 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-21 | New trial posted | Pulsed Stereotactic Ablative Radiotherapy (PULSAR) With Systematic Therapy for Thyroid Ca… |
| 2026-10-15 | New trial posted | Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study… |
| 2026-10-05 | New trial posted | Accelerated (Intensive) Cardiac Training for Heart Failure Patients |
| 2026-10-02 | New trial posted | Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS… |
| 2026-10-01 | New trial posted | Synthetic Electrospun Fiber Matrix in Abdominal Wall Donor Sites for Breast Reconstruction |
| 2026-09-30 | New trial posted | Online Perioperative Education Program on Patient Satisfaction and Clinical Outcomes for… |
| 2026-09-25 | New trial posted | Somatostatin Analogues vs. Observation After Peptide Receptor Radionuclide Therapy (PRRT)… |
| 2026-09-24 | New trial posted | Positron Emission Tomography (PET) Imaging of Chemotherapy-Induced Cardiotoxicity |
| 2026-09-22 | New trial posted | Postpartum Home Visiting (HEART at Home) |
| 2026-09-17 | New trial posted | Indocyanine Green With Near Infrared Imaging for Intraoperative Visualization of Head and… |
| 2026-09-15 | New trial posted | Resources and Education for Addressing Chronic Health (REACH) |
| 2026-09-09 | New trial posted | The BAARD Study : Evaluating a Computerized Approach to Treatment Selection in Older Adul… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT01760005 | Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Diseas… | Phase 2/3 | Active, not recruiting | Argentina, Australia, Brazil, Canada +12 |
| NCT06384573 | DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease | Phase 3 | Active, not recruiting | Australia, France, United Kingdom, United States |
| NCT04685590 | Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study | Phase 2 | Active, not recruiting | Spain, United States |
| 2024-517187-36-01 | A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled, Two-Stage Adaptive Design, Platform… | Phase 2/3 | Recruiting | Germany, Spain, France, Italy +1 |
| NCT06636149 | Maternal Maneuvers During Prolonged Labor | Not applicable | Recruiting | United States |
| NCT03482245 | The Role of Circadian Clock Proteins in Innate and Adaptive Immunity | Not applicable | Recruiting | United States |
| NCT03612193 | Role of the Gut Microbiome in Complex Regional Pain Syndrome | Not applicable | Recruiting | United States |
| NCT05738213 | Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine | Not applicable | Active, not recruiting | United States |
| NCT06636838 | Language Matters: Exploring the Impact of Language Concordance on Fertility Treatment Progression | Not applicable | Recruiting | United States |
| NCT06367465 | Feasibility and Acceptability of HCV Treatment in Pregnancy | Not applicable | Recruiting | United States |
| NCT04849871 | Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiati… | Not applicable | Active, not recruiting | United States |
| NCT07074288 | Obstructive Sleep Apnea Non-PAP Outcomes and Viable Alternatives | Not applicable | Recruiting | United States |
| NCT04015700 | Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma | Phase 1 | Active, not recruiting | United States |
| NCT06240754 | Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2A Decentraliz… | Phase 2 | Recruiting | United States |
| NCT04023591 | Nerve Transfer After Spinal Cord Injury- Multi-center | Not applicable | Active, not recruiting | Canada, United States |
| NCT07296887 | CARE Tool Study Aim 3 | Not applicable | Recruiting | United States |
| NCT07052305 | NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Marale… | Phase 1 | Recruiting | United States |
| NCT07462507 | Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1 | Phase 2 | Recruiting | United States |
| NCT07322445 | Multi-modal Imaging of Myofascial Pain - Phase 2 | Not applicable | Recruiting | United States |
| NCT02756962 | Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance | Phase 2 | Active, not recruiting | United States |
| NCT06391125 | LIMIT Trial - Lidocaine With Intramuscular Injection of Benzathine Penicillin G for Treponema Pallidum Treatm… | Phase 3 | Recruiting | United States |
| NCT07749547 | Using Personalized Rehabilitation to Reduce Disease and Increase Activity of Patients With Polymyalgia Rheuma… | Not applicable | Recruiting | United States |
| NCT07689162 | Liposomal Bupivacaine vs Standard Bupivacaine for Post-Rhinoplasty Analgesia | Phase 2 | Recruiting | United States |
| NCT05826457 | North American Prodromal Synucleinopathy Consortium Stage 2 | Not applicable | Recruiting | Canada, United States |
| NCT07072481 | Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing | Not applicable | Active, not recruiting | Nigeria |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Washington University School of Medicine clinical trials: 363 open, 63 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/washington-university-school-of-medicine/, data as of 2026-10-25.